News from the literature on a possible link between atherosclerosis and psoriasis and quality of life for patients with this skin condition.
For patients with heterozygous familial hypercholesterolemia, statin therapy is often not enough to reduce LDL cholesterol. In two articles in The Lancet, researchers report on promising results of two international Phase 3 trials of evolocumab.
The drug is a monoclonal antibody to proprotein convertase sudbtilism/kexin type 9 (PCSK9).
For individuals with hypercholesterolemia, research published in the Journal of American Medical Association provided recommendations on statin use for treating their condition prior to age 80.
Resistant hypertension is common among patients with type 2 diabetes, and is strongly associated with microvascular disease.
Long-term statin use among children with familial hypercholesterolemia is associated with normalization of carotid intima-media thickness progression, according to a research letter published online Sept. 9 in the Journal of the American Medical Association.
For patients after an acute coronary syndrome event, darapladib inhibition of lipoprotein-associated phospholipase A2 does not reduce the risk of major coronary events, according to a study published online Aug. 31 in the Journal of the American Medical Association. The study was published to coincide with the annual European Society of Cardiology Congress, held from Aug. 30 to Sept. 3 in Barcelona, Spain.